AstraZeneca to invest $50 billion in the U.S. as pharma tariffs weigh
-
最新报道：AstraZeneca announced plans to invest $50 billion in the U.S. over the next decade, expanding its research, manufacturing, and supply chain operations amid rising pharmaceutical tariffs. The move aims to strengthen the company's foothold in the American market while mitigating trade-related cost pressures. CEO Pascal Soriot emphasized the U.S. as a critical growth driver, citing demand for innovative medicines and vaccines. The investment is expected to create thousands of jobs and bolster local production capabilities. The decision comes as global pharma firms reassess supply chains due to geopolitical tensions and trade barriers.
下一篇
A whale withdrew 2,143 ETH from Binance and transferred it to TreehouseFi to obtain income
- According to the news from Bijie.com, according to the monitoring of Onchain Lens, a whale...
24小时热点
热点专题
410950